You may have noticed that your skin develops a sudden rash after eating peanut butter or a fussy tummy after consuming a bowl of kheer. The possible reason behind this may be a food allergy, as per a ...

Reducing dust buildup and controlling moisture inside the home can make a noticeable difference”— Falesity Mecca BATON ...

New research shows gut microbiota can metabolise peanut allergens and reduce IgE-mediated anaphylaxis severity. Learn more.

Early atopic dermatitis, allergic rhinitis, and infant wheeze showed the largest effect sizes. Skin barrier impairment metrics were independently associated with higher absolute food allergy risk.

Hey, first! We’re looking for your help. Can you take a couple minutes and fill out our Audience Survey? We’re dying to know more about the community that’s using this show — and about what’s working ...

(WXYZ) — In today’s Health Alert, data from nearly 3 million children shows that by age 6, as many as 1 in 20 may develop a food allergy. Researchers identified ...

Community programs like Go for Bold improve health, but lasting, equitable gains require complementary structural food policies—including taxes, reformulation, and labeling—to shift environments and ...

Medically reviewed by Maggie Moon, MS, RD Turmeric’s active compound, curcumin, offers powerful antioxidant and anti-inflammatory benefits.Research suggests curcumin may help protect your body against ...

The Trump administration is framing the new Dietary Guidelines not as nutrition advice, but as a federal systems strategy – using government procurement, institutional food programs and public ...

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...

In 2025, we were very pleased to report tremendous progress across all pillars of the company. First of all, in business development, we were delighted with the progress in our collaboration with MSD ...

ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it will present Phase 1/2 clinical data and Phase 3 ...